Fernandes Sabrina Alves, Tovo Cristiane Valle, da Silva André Luiz Machado, Pinto Letícia Pereira, Carteri Randhall B, Mattos Angelo A
Postgraduate Program in Hepatology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre 90050-170, Brazil.
Department of Infectology Service, Hospital Nossa Senhora da Conceição, Porto Alegre 91350-200, Brazil.
World J Hepatol. 2022 Jun 27;14(6):1173-1181. doi: 10.4254/wjh.v14.i6.1173.
Malnutrition, lipodystrophy, and dyslipidemia are prevalent characteristics in patients with human immunodeficiency virus (HIV) infection with or without previous treatment. Such a clinical condition can lead to the hypothesis of the presence of hepatic steatosis with possible progression to fibrosis and the risk of hepatocellular carcinoma. Notably, a low phase angle (PA), evaluated by bioelectrical impedance analysis (BIA), is an independent prognostic marker of clinical progression and survival in HIV-infected patients.
To evaluate the relationship between PA and body composition with steatosis and hepatic fibrosis in HIV/hepatitis C virus (HCV)-coinfected patients.
A retrospective observational study by convenience sampling of coinfected HIV/HCV patients, in which all patients underwent transient elastography (Fibroscan) and BIA evaluation. Student's test was used for group comparisons, and Spearman's or Pearson's correlation test was used when appropriate. The significance level was set at 5%, and analyses were performed using SPSS version 21.0.
Forty-three patients who received antiretroviral therapy met the inclusion criteria, and 23 (53.5%) were under treatment with protease inhibitors (PIs). There was no difference in PA between those who used PIs and those who did not ( = 0.635). There was no correlation between fibrosis grade and PA ( = 0.355) or lean mass ( = 0.378). There was a significant inverse correlation between the controlled attenuation parameter (CAP) and lean mass ( = 0.378), positive correlation between PA and lean mass ( = 0.378), and negative correlation between PA and fatty mass ( = 0.378), although the CAP and PA were not correlated. When evaluated by sex, no significant correlations were found.
PA determines the muscle function of HIV/HCV-coinfected patients, and the CAP values reinforce the association with lean mass, suggesting that patients require early nutritional interventions.
营养不良、脂肪代谢障碍和血脂异常是有或无既往治疗史的人类免疫缺陷病毒(HIV)感染者的常见特征。这种临床状况可引发肝脂肪变性的假说,且可能进展为肝纤维化及肝细胞癌风险。值得注意的是,通过生物电阻抗分析(BIA)评估的低相位角(PA)是HIV感染者临床进展和生存的独立预后标志物。
评估PA与身体成分在HIV/丙型肝炎病毒(HCV)合并感染患者的脂肪变性和肝纤维化之间的关系。
通过便利抽样对HIV/HCV合并感染患者进行回顾性观察研究,所有患者均接受瞬时弹性成像(Fibroscan)和BIA评估。采用学生t检验进行组间比较,适当情况下使用Spearman或Pearson相关检验。显著性水平设定为5%,使用SPSS 21.0版进行分析。
43例接受抗逆转录病毒治疗的患者符合纳入标准,其中23例(53.5%)正在接受蛋白酶抑制剂(PI)治疗。使用PI者与未使用者之间的PA无差异(P = 0.635)。纤维化分级与PA(P = 0.355)或瘦体重(P = 0.378)之间无相关性。控制衰减参数(CAP)与瘦体重之间存在显著负相关(P = 0.378),PA与瘦体重之间存在正相关(P = 0.378),PA与脂肪量之间存在负相关(P = 0.378),尽管CAP与PA不相关。按性别评估时,未发现显著相关性。
PA决定HIV/HCV合并感染患者的肌肉功能,CAP值强化了与瘦体重的关联,提示患者需要早期营养干预。